Archive · 1 Oct 2025
FDA Warns KEM Hospital Over Newborn Blood Shortage
KEM Hospital in Mumbai is having trouble providing fresh blood for newborns.
The Food and Drug Administration (FDA) has warned the hospital because they don't have enough blood for babies with jaundice.
Babies with jaundice need special blood transfusions to avoid brain damage.
Families have had to find blood from other places because KEM Hospital couldn't provide it.
The hospital's blood bank often separates blood too quickly, which makes it hard to have fresh blood ready.
The FDA wants the hospital to fix this problem right away to help babies get the blood they need.
The FDA warned KEM Hospital's blood bank due to a shortage of fresh blood for newborns.
Families struggled to obtain fresh blood for infants needing transfusions.
Complaints prompted action from the FDA and the State Blood Transfusion Council (SBTC).
The SBTC ordered an internal inquiry by KEM Hospital.
Paediatricians emphasize the importance of fresh blood for treating newborns with high bilirubin levels.
- Who
- FDA and KEM Hospital
- What
- FDA issued a warning to KEM Hospital over shortage of fresh blood for newborns.
- When
- Following repeated complaints in recent months.
- Where
- Mumbai, at KEM Hospital.
- Why
- KEM Hospital blood bank failed to provide fresh blood for newborns needing exchange transfusions, prompting families to seek blood elsewhere.
- Hospital
- KEM Hospital
- Location
- Mumbai
- Issue
- Shortage of fresh blood for newborns
- Action Taken
- FDA warning and SBTC inquiry
- Blood Type Mentioned
- O positive and A positive